Figure 9.

Inhibition of HIV-1 IIIB or BaL replication depends on the time of PJ-S21 addition pre- or post-infection. For comparison, the inhibition of infection by the nonnucleoside reverse transcriptase inhibitor TMC-120, added to cells at distinct intervals after HIV-1, was determined (dotted lines). Virus infection was measured by quantitation of β-galactosidase.